Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard R. Whipp | M | 70 | 13 years | |
Jost Fischer | M | 69 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 7 years |
Ed Inal | M | - |
Strathspey Crown LLC
Strathspey Crown LLC Investment ManagersFinance Strathspey Crown LLC (Strathspey Crown) is a private equity firm founded in 2012 by Robert Grant. The firm is headquartered in Newport Beach, California. | 3 years |
Jared Klumker | M | - |
Strathspey Crown LLC
Strathspey Crown LLC Investment ManagersFinance Strathspey Crown LLC (Strathspey Crown) is a private equity firm founded in 2012 by Robert Grant. The firm is headquartered in Newport Beach, California. | 6 years |
Stephen l Jang | M | - | 12 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Mulder | M | 63 | 2 years | |
Alexander Arrow | M | 53 | 4 years | |
Jeffrey W. Jones | M | 62 | 9 years | |
Robert Grant | M | 55 | 3 years | |
Jeffrey M. Nugent | M | 76 | 1 years | |
Murthy Simhambhatla | M | 58 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
Paul Clark | M | 76 | 3 years | |
Frederick D. Furry | M | 54 | 5 years | |
Frederick M. Capallo | M | 64 | 3 years | |
Marilyn A. Lobel | F | 70 | 1 years | |
Norman J. Nemoy | M | 84 | 4 years | |
James R. Talevich | M | 73 | 5 years | |
Gregory E. Lichtwardt | M | 69 | 3 years | |
Ehab M. Esmail | M | - | - | |
George V. D'Arbeloff | M | 79 | 14 years | |
Frederic Moll | M | 72 | 4 years | |
Samuel B. Low | M | - | 1 years | |
Brendan O'Connell | M | 47 | 12 years | |
Bosun Hau | M | 45 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | - |
Barton Bandy | M | 63 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
Orlando P. Rodrigues | M | 62 | - | |
Colleen M. Boswell | F | - | - | |
Peter Rowland | M | - | 6 years | |
Jake P. St. Philip | M | 71 | 1 years | |
Neil Laird | M | 70 | 4 years | |
Brett Scott | M | 73 | 1 years | |
Christopher Cox | M | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
James R. Largent | M | 74 | 3 years | |
Daniel S. Durrie | M | 73 | 4 years | |
John W. Hohener | M | 69 | 2 years | |
Richard L. Harrison | M | 67 | 3 years | |
Keith G. Bateman | M | 71 | 8 years | |
Gregory Waller | M | 74 | 1 years | |
Dennis Wolf | M | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Craig S. Kussman | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
Brian D. Jaffe | M | 63 | - | |
Erin Enright | F | 63 | - | |
Robert M. Anderton | M | 87 | 6 years | |
Ryan Meardon | M | 44 | 9 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 44 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Stevens
- Personal Network